Event’s website: http://www.smi-
There are only 2 weeks left before Pre-Filled Syringes Conference opens its doors to leading experts from big pharma companies including Pfizer, GSK, Merck & Co, Ipsen, Novo Nordisk and many others, to discuss how to overcome key challenges in your syringe and injection device development, including development of injection devices for biologics, minimising extractables and leachables within legislated guidelines and developments in fill, finish and inspection technologies.
KEY PRESENTATIONS INCLUDE:
Quality by design in the manufacture of pre-filled syringes
Advait Badkar, Associate Research Fellow, Technology Lead, Pfizer
Merck case study: Introduction of a prefilled diluents syringe for preparation of a complex product
Robert Schnepf, Molecule Leader, MPD CoE, Merck & Co.
Leachables and safety considerations in pre-filled syringes and cartridges: Impact on drug product quality and safety profile for biologics
Joel Richard, Vice President Peptides, Ispen
Development of HCLF Biologics in pre-filled syringes
Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
PLUS - Don't miss two post-conference interactive workshops:
A. Leachables and Extractables. Andrew Fieldon, Senior Consultant, Smithers Rapra
B. Large Volume Injectors- Technologies, Strategies and Guidance. Stephen Augustyn, Head of Mechanical Engineering, Team Consulting
Pre-Filled Syringes - 2014 is proud to be sponsored by BD, Schott, Owen Mumford, West, VJ Electronix, Schreiner MediPharm, Nolato Medical, Astech Projects and Zeon. To learn how you can benefit from our event and introduce your company and its services to a key decision-makers in the industry, contact Alia Malick, Director, via amalick@smi-
Register online here http://www.smi-